Modern medical device software and AI demands industry-specific knowledge from every part of your regulatory team. This panel of industry experts will cover cloud-based medical device software and AI practices
Continue Reading Join us: What you need to know: AI and Software for Healthcare
Congratulations to AMC Health, a longstanding client of GT, for securing a strategic growth investment from York Private Equity, the private investing arm of York Capital Management.
AMC Health is
Continue Reading GT Telehealth Client Secures Strategic Growth Investment
Congratulations to our longstanding client, Enlivex Therapeutics Ltd. (“Enlivex”, NASDAQ: ENLV), which recently announced the successful completion of a $51.3 million offering of its Ordinary Shares. Leading the transaction on
Continue Reading Congratulations to longstanding GT Client Enlivex on Completing Multi-Million Dollar Offering
Congratulations to our client Medigate for being featured on Forbes’ Top 20 IoT Startups To Watch In 2020.
Medigate is a company operating in Israel and in the US.
Continue Reading GT Client Medigate Makes Forbes’ Top 20 IoT Startups To Watch In 2020
Coronavirus Disease 2019 (COVID-19) is causing unprecedented disruptions to the U.S. economy. Government officials and health professionals are predicting that these disruptions could continue through September. Businesses are having to
Continue Reading Risk Allocation for Economic Losses from Coronavirus Disease 2019
While it is too early to predict how long the Coronavirus Disease 2019 (COVID-19) will disrupt everyday life, it isn’t too soon to proactively consider your potential risk and understand
Continue Reading Coronavirus Disease 2019 and Force Majeure Contract Clauses
The United States Attorney’s Office for the Southern District of Florida announced on Sept. 19, 2019, that it settled a qui tam False Claims Act case in which a private
Continue Reading 2 Recent Cases Impacting False Claims Act Litigation and Investigations Deserve the Attention of Health Care Providers and Private Equity Investors
A team of Greenberg Traurig attorneys recently represented Intec Pharma Ltd. (NASDAQ and TASE: NTEC) on the closing of its offering of approximately 12.2 million of its ordinary shares, at
Continue Reading Greenberg Traurig Advises Intec Pharma on $57.5M Offering
A Greenberg Traurig team of attorneys in Tel Aviv, Fort Lauderdale, Miami, Boston, and New York recently represented BioTelemetry Inc., a publicly traded company based in Pennsylvania, in its $280
Continue Reading GT Attorneys in Tel Aviv and Other GT Offices Represent Medical Tech Company in $280M Deal
Welcome to Greenberg Traurig’s Health Care & FDA Practice Bulletin, a collection of timely articles written by our attorneys that are focused on significant developments in health and FDA law.
Continue Reading Health Care & FDA Practice Bulletin No. 5